Butylate
CAS: 2008-41-5
Ref. 3D-FB156943
| 1g | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Butylate
Sinónimos:
- Bis(2-methylpropyl)carbamothioic acid S-ethyl esterS-Ethyl N,N-diisobutylthiocarbamate
- Anelda
- Butilate
- Carbamic acid, diisobutylthio-, S-ethyl ester
- Carbamothioic acid, N,N-bis(2-methylpropyl)-, S-ethyl ester
- Carbamothioic acid, bis(2-methylpropyl)-, S-ethyl ester
- Diisocarb
- Ethyl N,N-diisobutylthiocarbamate
- Ethyl-N,N-diisobutyl thiolcarbamate
- R 1910
- Ver mais sinónimos
- S-Ethyl N,N-diisobutylthiocarbamate
- S-Ethyl N,N-diisobutylthiolcarbamate
- S-ethyl bis(2-methylpropyl)carbamothioate
- S-ethyl diisobutylthiocarbamate
- Stauffer R 1910
- Sutan
Descrição:
Butylate belongs to the class of drugs used to treat metabolic disorders. It is a prodrug that is converted by hydrolysis to its active form, butyric acid. The bound form of butylate has been shown to be effective in vitro assays and can be used as a precursor for solid catalysts. Butylate has been shown to have anticancer effects in vitro and also affects protein synthesis. This drug also inhibits prostaglandin synthesis and has an anti-inflammatory effect.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
217.37 g/mol
Fórmula:
C11H23NOS
Pureza:
Min. 95%
InChI:
InChI=1S/C11H23NOS/c1-6-14-11(13)12(7-9(2)3)8-10(4)5/h9-10H,6-8H2,1-5H3
Chave InChI:
InChIKey=BMTAFVWTTFSTOG-UHFFFAOYSA-N
SMILES:
CCSC(=O)N(CC(C)C)CC(C)C
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
